Choosing the right heart stent can feel overwhelming—so many options, and every decision matters for patient health. With countless manufacturers across the USA, how do you know which supplier truly stands out? Top-quality stents mean better outcomes, smoother procedures, and peace of mind for everyone involved. Curious about which American factories lead the pack? Dive in as we break down the industry’s top heart stent manufacturers and help you find the very best. Let’s get started!

Related Video

Best Coronary Stents from the Top Brands – iData Research

Product Details:
Boston Scientific offers the SYNERGY™ and REBEL™ coronary stent product lines. SYNERGY™ is the first and only FDA-approved drug-eluting stent (DES) with abluminal bioabsorbable polymer coating available in the U.S. market. REBEL™ is a bare-metal stent (BMS) made of platinum chromium alloy designed to reduce device usage, procedure times, and radiation exposure. Medtronic provides the Resolute Onyx™, Resolute Integrity™ DES, and Integrity™ BMS, with its DES using zotarolimus drug, different from everolimus used by competitors.

Abbott offers the XIENCE™ drug-eluting stent and Multi-Link Vision™ BMS, constructed from cobalt-chromium alloy for higher radiopacity and strength.

Technical Parameters:
– SYNERGY™: Drug-eluting stent with abluminal bioabsorbable polymer coating;
– REBEL™: Bare-metal stent made from platinum chromium alloy to reduce device
– XIENCE™: Drug-eluting stent using everolimus drug.
– Multi-Link Vision™: Bare-metal stent constructed from cobalt-chromium alloy,

Application Scenarios:
– Used in percutaneous coronary intervention (PCI) following angioplasty to keep
– Primarily applied in patients at risk of artery collapse after angioplasty.
– Covered stents are used for treating free perforations in native coronary
– Bifurcated stents used in complex coronary lesions involving artery branches.

Pros:
– Drug-eluting stents (DES) significantly reduce risk of scar tissue growth and
– Abluminal bioabsorbable polymer coating in SYNERGY™ minimizes long-term polymer
– Platinum chromium and cobalt-chromium alloys enable thinner, stronger, and more
– DES and advanced BMS technologies reduce procedural times and radiation

Cons:
– Overall market shows declining value and negative growth, partly due to
– Bare-metal stents losing market share and expected to continue contracting with
– Covered stents and bifurcated stents represent small market fractions and are
– Bifurcated stents experienced initial sales decline due to lack of supporting

Top 21 Companies Shaping the Cardiovascular Device Domain – Inven

Product Details:
The companies offer a wide variety of cardiovascular medical devices and technologies, including telemedicine services, home monitoring systems, ablation devices, balloon angioplasty systems, stents (including drug-eluting and bifurcation stents), biodegradable coatings, artificial hearts (such as SynCardia Total Artificial Heart and Carmat Aeson® TAH), occluders, interatrial shunt products, circulatory assist devices, catheter-based pumps, defibrillators, cardiac resynchronization therapy devices, and comprehensive design/manufacturing services for medical components (Paragon Medical). Some companies also provide pharmaceuticals or food supplements related to cardiovascular health.

Technical Parameters:
– Products include advanced devices such as drug-eluting stents, biodegradable
– Some devices utilize proprietary technology and are backed by several patents
– Remote monitoring/home monitoring platforms reduce in-person care requirements
– Artificial heart devices (like SynCardia and Carmat Aeson® TAH) support

Application Scenarios:
– Diagnosis, treatment, and monitoring of cardiovascular diseases such as
– Remote patient care and reduction of doctor visits for post-acute
– Assisting patients with severe cardiac conditions (e.g., total artificial heart
– Interventional cardiology and surgical procedures (e.g., use of stents,

Pros:
– Broad product portfolios offering innovative solutions in interventional and
– Products support minimally invasive and remote monitoring approaches, improving
– Some devices leverage advanced/highly-patented proprietary technologies
– Remote monitoring and telemedicine reduce hospital visits and associated

Cons:
– Limited clinical experience or long-term outcomes for some newer/highly
– High cost and potentially limited accessibility for advanced/articulated
– Device complexity may pose training demands for healthcare professionals.

Top 10 Stents Companies | Verified Market Research

Coronary Stents – Boston Scientific

Top 10 Companies in Coronary Stents Market in 2024 – Emergen Research

Product Details:
Coronary stents including bare-metal stents, drug-eluting stents, and advanced solutions such as the XIENCE Stent (Abbott), Absorb Bioresorbable Vascular Scaffold (Abbott), Zilver PTX Drug-Eluting Stent (Cook Medical), as well as stent portfolios from Medtronic, Boston Scientific, Braun Melsungen AG, Terumo Corporation, and others.

Technical Parameters:
– Drug-eluting and bare-metal stents
– Bioresorbable scaffold technology (e.g., Abbott Absorb)
– Thinner struts and biocompatible coatings for improved flexibility
– Regulatory approvals in over 160 countries (e.g., Terumo Corporation)

Application Scenarios:
– Treatment of narrowed or blocked coronary arteries
– Procedures during angioplasty to prevent restenosis
– Management of coronary artery disease associated with risk factors like high
– Improving blood flow to the heart to reduce risk of heart attack

Pros:
– Reduces risk of restenosis and re-narrowing of arteries
– Improved blood flow to the heart and patient quality of life
– Advancements like drug-eluting coatings and bioresorbable stents enhance
– Personalized stents can be tailored to individual patient needs

Cons:
– Market growth may be hindered by alternative, less invasive treatments
– Potential competition from evolving diagnostic and therapeutic methods

Coronary stent – All medical device manufacturers

Product Details:
The page lists multiple coronary stents from various companies, including drug eluting stents (DES), polymer-free stents, biodegradable stent platforms, and novel stent technologies (e.g., dual therapy stents, abluminal reservoir technology, ultrathin struts). Products shown feature various drug coatings (sirolimus, everolimus, amphilimus, novolimus), stent materials (cobalt-chromium, poly-L-lactide), and design approaches (ultrathin struts, hybrid cell design, fully degradable platforms).

Technical Parameters:
– Diameters range: 2 mm – 5 mm
– Lengths range: 7 mm – 43 mm
– Drug coatings: Sirolimus, Everolimus, Rapamycin, Amphilimus (sirolimus + fatty
– Materials: Polymer-free, biodegradable poly(L-lactide), cobalt-chromium alloy

Application Scenarios:
– Treatment of de novo stenotic coronary artery lesions
– Management of in-stent restenotic lesions
– Patients undergoing percutaneous coronary interventions (angioplasty)
– Use in vessels requiring high flexibility and conformability (e.g., tortuous

Pros:
– Drug eluting stents reduce the risk of restenosis and late stent thrombosis
– Polymer-free and biodegradable designs minimize inflammatory response and
– Ultrathin and flexible strut designs improve deliverability and endothelializati
– Advanced stent structures (e.g., dual therapy, hybrid cell) support better

Cons:
– Risks remain for stent thrombosis (clotting) and vessel rupture post-procedure
– Polymer-based or metallic components may still carry kidney and restenosis

Stents – Heart Stents, Cardiac Stent, Coronary Stents, Esophageal …

Product Details:
Paragon Medical, through its Laserage brand, specializes in manufacturing a wide range of medical stents for OEMs worldwide, utilizing advanced laser processing on metals and polymers. Stents produced include coronary, peripheral artery, biliary, ureteral, esophageal, and airway stents, with options including bare metal, drug-eluting, bioabsorbable, plastic, and self-expanding or balloon-expandable types.

Technical Parameters:
– Materials: Stainless steel, cobalt-chromium alloys, nitinol, biodegradable
– Types: Bare metal stents (BMS), drug-eluting stents (DES), bioabsorbable stents
– Coatings: Drug coatings (sirolimus, paclitaxel, everolimus), biocompatible
– Designs: Double-J, open-ended, covered/uncovered metal, various loop/expansion

Application Scenarios:
– Coronary artery disease (CAD) and interventional cardiology to restore blood
– Peripheral artery disease (PAD) to treat narrowed or blocked vessels in limbs
– Relief of biliary and ureteral obstructions to facilitate bile or urine drainage
– Treatment of esophageal and airway obstructions due to tumors, strictures, or

Pros:
– Wide material and design choices accommodate diverse clinical needs and vessel
– Drug-eluting and bioabsorbable options help reduce restenosis and enable vessel
– Advanced laser processing enables high precision and complex geometries
– Self-expanding and balloon-expandable variants for optimized placement and

Cons:
– Permanent metal stents may remain in the body, potentially causing long-term
– Plastic biliary stents often require replacement for long-term management
– Potential for adverse reactions if biocompatibility is not optimal or in
– Bioabsorbable stents may have limitations in strength or predictability of

Coronary Stents – Medtronic

XIENCE™ Family of Drug-Eluting Stents – Abbott Cardiovascular

Product Details:
The XIENCE family consists of drug-eluting stents used for percutaneous coronary intervention (PCI) to treat patients with coronary artery disease. XIENCE stents deliver everolimus, an anti-proliferative drug, via a durable fluoropolymer coating designed to reduce restenosis following stent implantation.

Technical Parameters:
– Everolimus-eluting stent with a durable fluoropolymer coating
– Cobalt chromium platform for improved deliverability and flexibility
– Available in a range of diameters (2.25–4.0 mm) and lengths (8–38 mm)
– Thin strut design (as thin as 81 μm, variable by model)

Application Scenarios:
– Used in percutaneous coronary intervention (PCI) procedures
– Treats patients with coronary artery disease (CAD)
– Applicable for de novo coronary artery lesions

Pros:
– Proven long-term safety with low rates of stent thrombosis
– Demonstrated reduction in target lesion revascularization compared to
– Flexible delivery system supports ease of navigation in complex anatomies
– Well-established clinical data supporting efficacy and safety

Cons:
– Requires dual antiplatelet therapy post-implant, which may not suit all patients
– Possible risk of late stent thrombosis, although rates are low
– Limited effectiveness in very small vessels or highly calcified lesions

Cardiovascular medical devices: Stent manufacturer | Medinol

Product Details:
Medinol develops and manufactures cardiovascular intervention devices, including innovative stent systems such as the EluNIR and NIRxcell, designed for the treatment of coronary artery disease.

Technical Parameters:
– EluNIR stent system features a thin-strut cobalt chromium platform with a
– Stents have enhanced deliverability and conformability for complex anatomies.
– EluNIR utilizes a drug-eluting polymer coating for controlled drug release.
– Compatibility with standard balloon catheters and multiple vessel sizes.

Application Scenarios:
– Percutaneous coronary interventions (PCI) for patients with coronary artery
– Treatment of complex and tortuous coronary anatomies.
– Cases requiring drug-eluting stents to reduce restenosis rates.

Pros:
– Proprietary single-strut design improves flexibility and conformability in
– Thin-strut platform enhances deliverability and reduces vessel trauma.
– Controlled drug release reduces the risk of restenosis.
– Clinically proven performance in complex coronary anatomies.

Cons:
– Limited long-term outcome data for newest device generations.
– May require specific physician training for optimal deployment in complex

Comparison Table

Frequently Asked Questions (FAQs)

How do I find reputable heart stent manufacturers based in the USA?
Start by researching through industry directories, medical device trade associations, and FDA databases. Attending trade shows and consulting with healthcare professionals can also help identify well-established American manufacturers.

What certifications should a reliable heart stent manufacturer have?
Look for manufacturers with FDA approval and ISO 13485 certification, as these confirm compliance with U.S. quality standards and international medical device regulations.

Can I request samples or product demonstrations before making a large order?
Absolutely! Most credible manufacturers are happy to provide samples or organize demonstrations so you can assess product quality and suitability before committing to a partnership.

How can I evaluate the manufacturing capabilities of a supplier?
Ask about their production facilities, capacity, quality control processes, and technological expertise. Visiting the factory or conducting a virtual tour can also help you gauge their capabilities firsthand.

What factors should I consider when comparing multiple heart stent suppliers?
Compare product quality, compliance records, customer service, lead times, customization options, and pricing. Choosing a supplier with strong communication and after-sales support is also beneficial for long-term partnerships.